Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Return on Assets (2016 - 2025)

Historic Return on Assets for Editas Medicine (EDIT) over the last 10 years, with Q3 2025 value amounting to 0.96%.

  • Editas Medicine's Return on Assets fell 3700.0% to 0.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.96%, marking a year-over-year decrease of 3700.0%. This contributed to the annual value of 0.56% for FY2024, which is 2600.0% down from last year.
  • Per Editas Medicine's latest filing, its Return on Assets stood at 0.96% for Q3 2025, which was down 3700.0% from 0.99% recorded in Q2 2025.
  • Editas Medicine's 5-year Return on Assets high stood at 0.21% for Q1 2021, and its period low was 0.99% during Q2 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.37% (2023), whereas its average is 0.46%.
  • Per our database at Business Quant, Editas Medicine's Return on Assets soared by 1200bps in 2023 and then plummeted by -5200bps in 2025.
  • Quarter analysis of 5 years shows Editas Medicine's Return on Assets stood at 0.28% in 2021, then tumbled by -53bps to 0.42% in 2022, then rose by 28bps to 0.3% in 2023, then tumbled by -135bps to 0.71% in 2024, then crashed by -35bps to 0.96% in 2025.
  • Its Return on Assets stands at 0.96% for Q3 2025, versus 0.99% for Q2 2025 and 0.83% for Q1 2025.